Why Graham (GHM) Is Up 9.0% After Issuing 2027 Sales Guidance And Mixed Q4 Results
Graham Corporation GHM | 0.00 |
- Graham Corporation recently reported fourth-quarter fiscal 2026 results, with sales rising to US$67.08 million but net income easing to US$1.97 million, and issued fiscal 2027 net sales guidance of US$285 million to US$295 million.
- Despite only a modest full-year net income increase to US$12.50 million, the company’s willingness to provide 2027 guidance gives investors clearer visibility into its near-term revenue expectations.
- We’ll now examine how Graham’s new 2027 sales guidance range reframes its existing investment narrative and expectations for future performance.
AI is about to change healthcare. These 40 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
Graham Investment Narrative Recap
To own Graham today, you need to believe its record backlog and exposure to defense, energy transition and space can translate into steadily improving earnings quality. The new fiscal 2027 sales guidance of US$285 million to US$295 million reinforces near term revenue visibility, but the softer fourth quarter profit reminds me that margin sustainability remains the key short term catalyst and that heavy reliance on defense and fossil fuel related demand is still the biggest risk. The latest update does not fundamentally change those priorities.
The most relevant recent announcement is Graham’s guidance increase earlier in fiscal 2026, when it lifted expected net sales to US$233 million to US$239 million. Taken together with the new 2027 outlook, this sequence of guidance steps gives a clearer picture of how management sees the backlog converting into revenue, which matters directly for assessing whether productivity investments and mix shifts can support margins rather than simply driving higher, but less profitable, sales.
Yet beneath the promising revenue guidance, investors should be aware of how margin pressure and contract concentration could...
Graham's narrative projects $347.5 million revenue and $32.8 million earnings by 2029. This requires 13.5% yearly revenue growth and a $17.9 million earnings increase from $14.9 million today.
Uncover how Graham's forecasts yield a $100.25 fair value, a 4% downside to its current price.
Exploring Other Perspectives
Compared with the consensus view, the lowest analysts were already cautious, assuming revenue of about US$290.2 million and earnings of US$31.6 million by 2028, and your own assessment of Graham’s new 2027 sales guidance and defense heavy backlog risk could either narrow or widen that gap in expectations.
Explore 3 other fair value estimates on Graham - why the stock might be worth less than half the current price!
Reach Your Own Conclusion
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
- A great starting point for your Graham research is our analysis highlighting 2 key rewards that could impact your investment decision.
- Our free Graham research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Graham's overall financial health at a glance.
Seeking Other Investments?
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
- The future of work is here. Discover the 33 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
- Uncover the next big thing with 24 elite penny stocks that balance risk and reward.
- Explore 29 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
